M12.29
Villonodular synovitis (pigmented), multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Villonodular synovitis, also known as pigmented villonodular synovitis (PVNS), is a joint condition characterized by the abnormal growth of the synovial membrane—the lining of joints. When it occurs in multiple sites, it can affect several joints simultaneously, leading to pain and swelling. This condition is classified under ICD-10 code M12.29 and mainly affects adults, although it can occur at any age.
Causes & Symptoms
Clinical Causes: The exact cause of PVNS is unknown, but it is believed to result from abnormal proliferation of synovial cells. Some theories suggest it could be related to a benign neoplastic process or inflammatory response. Previous joint injury or trauma may be associated with the development of PVNS in some cases. Genetic factors could potentially play a role, although research is ongoing.
Key Symptoms: Persistent joint swelling and stiffness Localized pain, which may worsen with activity Reduced joint mobility and difficulty moving the affected joints A feeling of joint warmth or tenderness In cases affecting multiple sites, symptoms might be widespread or involve several joints simultaneously In some instances, joint loosing or instability due to tissue damage
Diagnostic & Treatment
Diagnosis Path: Diagnosis of pigmented villonodular synovitis involves a combination of clinical evaluation and imaging tests. Doctors will typically perform a physical exam to assess swelling, tenderness, and range of motion. Imaging studies include:
Treatment Protocols: Managing PVNS typically involves surgical removal of the abnormal synovial tissue, known as synovectomy. The goal is to reduce joint swelling, alleviate pain, and prevent joint destruction. Depending on the severity and sites involved, options include:
Clinical Advice & FAQs
Billing Guidance
Is M12.29 a billable ICD-10 code?
Yes, M12.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M12.29?
Clinical documentation must specify the nature of Villonodular synovitis (pigmented), multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference